Radiology departments at hospitals continue to face significant capacity constraints, while imaging procedures often remain a frustrating experience for patients. Health systems and imaging centers are managing growing demand for medical scans despite aging equipment and limited scanner availability. Patients, meanwhile, frequently encounter long waiting periods, and imaging procedures can be uncomfortable or anxiety-inducing.
Subtle Medical, a health technology startup based in California, is seeking to address these issues through artificial intelligence-powered imaging software designed to produce quicker, higher-quality scans with reduced manual effort. The company argues that prolonged imaging procedures can compromise image quality, postpone diagnoses and restrict scanner availability. Its software enhances image quality while shortening scan times on existing systems, enabling providers to improve throughput without investing in additional hardware.
Subtle Medical is developing an enterprise-level AI platform for medical imaging aimed at improving operational efficiency for healthcare providers while also benefiting patients through shorter MRI scan durations and reduced radiation exposure.
The company originated from Stanford University and was founded by Greg Zaharchuk and Enhao Gong. The startup created vendor-neutral software powered by machine learning and generative AI to enhance image quality across both standard and rapid imaging protocols, allowing radiologists to deliver care more efficiently.
As it prepares for a new stage of commercial expansion, Subtle Medical secured $33 million in growth funding through a Series C financing round led by funds managed by Morgan Stanley Expansion Capital. To date, the company has raised a total of $86 million.
The new capital will support product development, global commercial expansion and the scaling of the company’s vendor-neutral imaging platform across MRI, PET and CT modalities.
Alongside the funding announcement, Subtle Medical appointed Ohad Arazi as CEO, replacing Gong in the role. Gong will transition to chief science officer, where he will oversee scientific development while continuing to support operational initiatives and partnerships in China.
In a statement, Gong explained that Subtle Medical was established to make advanced imaging quicker, safer and more widely accessible. He added that the company’s next stage of growth would focus on expanding the scientific foundation of its platform while broadening its role in global imaging systems.
Subtle Medical’s AI products are currently implemented in more than 1,300 scanners across major imaging providers, academic medical centers and health systems globally. Customers such as Mount Sinai Health System, RadNet and Radiology Partners have reportedly experienced measurable improvements in workflow efficiency, patient throughput and overall experience. The company has also obtained 11 clearances from the U.S. Food and Drug Administration and published more than 25 peer-reviewed studies.
Subtle Medical has developed multiple deep-learning technologies aimed at enhancing MRI image quality, shortening exam times and reducing manual workload. These tools are designed to help providers generate clearer scans, improve workflow efficiency and extend the useful lifespan of existing scanners. Its PET-focused software, SubtlePET, improves image quality while enabling faster scans at lower radiation doses, potentially making imaging safer and more comfortable for patients without reducing diagnostic precision.
Subtle Medical has announced the successful completion of a $33 million Series C funding round alongside the appointment of a new chief executive officer. The latest developments mark a significant milestone for Subtle Medical as the company continues to expand its presence in the rapidly growing field of artificial intelligence-driven medical imaging.
The funding is expected to support product innovation, market expansion, and strategic initiatives designed to strengthen the position of Subtle Medical within the healthcare technology industry.
Subtle Medical Strengthens Growth Strategy
The new investment reflects growing confidence in the vision and technology developed by Subtle Medical. As healthcare providers increasingly seek AI-powered tools to improve imaging efficiency and diagnostic workflows, Subtle Medical is well positioned to address evolving industry needs.
The additional capital will enable Subtle Medical to scale operations, enhance product development efforts, and expand its global customer base.
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
- Editorial Team
